Table 1 organizes recent studies investigating the use of GLP analogs and DPP-IV inhibitors in IBD by study design, treatment arm, key results, and evidence classification with risk-of-bias assessment
They redirected clinical questions to the in-app care team
Pharmacokinetics, distribution, metabolism, and excretion of bodyprotective compound 157 (BPC 157), a potential drug for treating various wounds, in rats and dogs. Frontiers in Pharmacology , 13 , Article 102618
The combined result is a potent and sustained reduction in appetite and caloric intake that has been consistently demonstrated across large-scale clinical trials
The large image can be enlarged further using the zoom button by the main image
Wang T, Arifoglu P, Ronai Z and Tew KD